“ Chronic Hepatitis C Treatment for Genotype 2 or 3 in Brazil: Cost Effectiveness Analysis of Peginterferon Plus Ribavirin As First Choice Treatment ”. Brazilian Journal of Pharmaceutical Sciences 50, no. 2 (April 1, 2014): 345–352. Accessed May 29, 2024. https://www.revistas.usp.br/bjps/article/view/86942.